SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 1, 2002 (May 1, 2002)
ENDO PHARMACEUTICALS HOLDINGS INC.
------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 39040 13-4022871
------------------------------------------------------------------------------
(State or other (Commission File Number) (I.R.S. Employer
jurisdiction of Identification No.)
incorporation)
100 Painters Drive
Chadds Ford, Pennsylvania 19317
------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(610) 558-9800
------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
N/A
------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 7. Financial Statements and Exhibits.
----------------------------------
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
Exhibit Number Description
-------------- -----------
99.1 Slide Presentation of Endo Pharmaceuticals Holdings Inc.
dated May 1, 2002
99.2 Slide Presentation of Endo Pharmaceuticals Holdings Inc.
dated May 2, 2002
Item 9. Regulation FD Disclosure.
-------------------------
On May 1, 2002, the Registrant intends to make a slide
presentation at the CIBC World Markets Biotechnology & Specialty
Pharmaceuticals Conference in New York, New York, a copy of which
presentation is filed herewith as Exhibit 99.1 and is incorporated herein
by reference.
In addition, the Registrant intends to make a slide presentation
to affiliates of Kelso & Company on May 2, 2002. A copy of this slide
presentation is filed herewith as Exhibit 99.2 and is incorporated herein
by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
ENDO PHARMACEUTICALS HOLDINGS INC.
(Registrant)
By: /s/ Caroline B. Manogue
-----------------------
Name: Caroline B. Manogue
Title: Senior Vice President,
General Counsel & Secretary
Dated: May 1, 2002
INDEX TO EXHIBITS
Exhibit Number Description
-------------- -----------
99.1 Slide Presentation of Endo Pharmaceuticals Holdings Inc.
dated May 1, 2002
99.2 Slide Presentation of Endo Pharmaceuticals Holdings Inc.
dated May 2, 2002